enVVeno Medical Corporation (NVNO)

NASDAQ: NVNO · Real-Time Price · USD

10.84

-0.21 (-1.90%)

At close: Jun 26, 2026, 4:00 PM EDT

11.00

+0.16 (1.48%)

After-hours: Jun 26, 2026, 4:10 PM EDT

enVVeno Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.6	3.07	1.75	3.62	4.56	54.73
Short-Term Investments	22.33	25.15	41.4	42.79	34.49	-
Cash & Short-Term Investments	24.93	28.21	43.15	46.41	39.04	54.73
Cash Growth	-35.98%	-34.62%	-7.02%	18.87%	-28.66%	486.29%
Other Current Assets	0.56	0.61	0.58	0.51	0.39	0.31
Total Current Assets	25.49	28.83	43.73	46.92	39.44	55.04
Net Property, Plant & Equipment	0.58	0.71	1.19	1.68	2.19	2.61
Other Long-Term Assets	0.03	0.03	0.03	0.03	0.03	0.05
Total Assets	26.1	29.56	44.95	48.64	41.66	57.7
Accounts Payable	1.75	1.73	1.73	1.03	1.22	0.56
Accrued Expenses	-	-	-	-	-	0.73
Current Portion of Leases	0.4	0.39	0.36	0.34	0.31	0.29
Total Current Liabilities	2.14	2.12	2.1	1.37	1.53	1.58
Long-Term Leases	0.21	0.31	0.7	1.06	1.4	1.72
Total Long-Term Liabilities	0.21	0.31	0.7	1.06	1.4	1.72
Total Liabilities	2.35	2.43	2.8	2.44	2.93	3.3
Additional Paid-in Capital	198.92	198.46	194.01	176.24	145.25	136.26
Retained Earnings	-175.18	-171.33	-151.86	-130.04	-106.52	-81.85
Shareholders' Equity	23.75	27.13	42.16	46.2	38.73	54.4
Total Liabilities & Equity	26.1	29.56	44.95	48.64	41.66	57.7
Total Debt	0.6	0.7	1.06	1.4	1.72	2.01
Net Cash (Debt)	24.33	27.51	42.09	45.01	37.33	52.72
Net Cash Growth	-11.58%	-34.63%	-6.49%	20.58%	-29.20%	523.64%
Net Cash Per Share	40.07	46.71	85.90	128.07	116.34	212.59
Book Value	23.75	27.13	42.16	46.2	38.73	54.4
Book Value Per Share	39.11	46.06	86.04	131.46	120.71	219.37
Tangible Book Value	23.75	27.13	42.16	46.2	38.73	54.4
Tangible Book Value Per Share	39.11	46.06	86.04	131.46	120.71	219.37

SEC Filings: 10-K · 10-Q